ABSTRACT
The cancer clinical therapy of doxorubicin (Dox) treatment is limited by its life-threatening cardiotoxic effects. Dickkopf-1 (Dkk1), the founding and best-studied member of the Dkk family, functions as an antagonist of canonical Wnt/β-catenin. Dkk1 is considered to play a broad role in a variety of biological processes, but its effects on Dox-induced cardiomyopathy are poorly understood. Here, we found that the level of Dkk1 was significantly increased in Dox-treated groups, and this increase exacerbated Dox-induced cardiomyocyte apoptosis and mitochondrial dysfunction. Overexpressing Dkk1 aggravated Dox-induced cardiotoxicity in H9C2 cells. Similar results were detected when adding active Dkk1 protein extracellularly. Conversely, adding specific antibody blocking extracellular Dkk1 attenuated the cardiotoxic response to Dox. Adenovirus encoding Dkk1 was transduced through intramyocardial injection and exacerbated Dox-induced cardiomyocyte apoptosis, mitochondrial damage and heart injury in vivo. Furthermore, Wnt/β-catenin signaling was inhibited during Dox-induced cardiotoxicity, and the re-activation of β-catenin prevented the effect of overexpressed Dkk1 and Dox-induced cardiotoxicity. In conclusion, these results reveal the crucial role of the Dkk1–Wnt/β-catenin signaling axis in the process of Dox-induced cardiotoxicity and provide novel insights into the potential mechanism of cardiomyopathy caused by clinical application of Dox.
Footnotes
Competing interests
The authors declare no competing or financial interests.
Author contributions
Conceptualization: L.L., J.L., P.L.; Methodology: L.L., Y.T., P.W., Z.G., Q.W., K.G., R.L.; Software: L.L., Y.T., P.W., Z.G.; Validation: L.L., J.L., P.L.; Formal analysis: L.L., J.L., P.L.; Investigation: L.L., P.W., Z.G., Q.W., K.G., R.L.; Resources: J.L., H.L., P.L.; Data curation: L.L., Y.T.; Writing - original draft: L.L.; Writing - review & editing: Y.T., J.L., P.L.; Visualization: L.L., P.W., Z.G.; Supervision: J.L., P.L.; Project administration: J.L., P.L.; Funding acquisition: J.L., H.L., P.L.
Funding
This research was supported by grants from the National Natural Science Foundation of China (81803521, 81872860, 81673433), Indigenous Innovative Research Team of Guangdong Province (2017BT01Y093), the National Major Special Projects for the Creation and Manufacture of New Drugs (2018ZX09301031-001), the Special Program for Applied Science and Technology of Guangdong Province (2015B020232009), the National Engineering and Technology Research Center for New Drug Druggability Evaluation (Seed Program of Guangdong Province, 2017B090903004), the Guangzhou Science and Technology Program Project (201604020121), Medical Scientific Research Foundation of Guangdong Province (A2018078), the Traditional Chinese Medicine Bureau of Guangdong Province (20191060) and the Natural Science Foundation of Guangdong Province (2017A030310542).
Supplementary information
Supplementary information available online at http://jcs.biologists.org/lookup/doi/10.1242/jcs.228478.supplemental
- Received December 2, 2018.
- Accepted April 9, 2019.
- © 2019. Published by The Company of Biologists Ltd
Log in using your username and password
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$30.00 .
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Review – Microtubules at focal adhesions – a double-edged sword
In their new review, Shailaja Seetharaman and Sandrine Etienne-Manneville discuss the direct and indirect crosstalk between focal adhesions and microtubules.
Review – Tissue-specific roles of p73 in development and homeostasis
While p73 has functions in cancer, Alice Nemajerova and Ute Moll’s review focuses on its non-oncogenic activities, as displayed in p73 knockout mice.
Cell Scientist to Watch – Elif Nur Firat-Karalar
Elif Nur Firat-Karalar's studies have taken her from Turkey to the USA and back again, where she is now Assistant Professor at Koç University in Istanbul, focusing on the structure and function of the mammalian centrosome/cilium complex.
Catch up with early-career first authors in our First Person interviews. Recently, we spoke to Min Jae Kim, Osvaldo Contreras and Ebtissal Khouj.
Travelling Fellowship – New imaging approach unveils a bigger picture
Find out how Pamela Imperadore’s Travelling Fellowship grant from The Company of Biologists took her to Germany, where she used new imaging techniques to investigate the cellular machinery underlying octopus arm regeneration.
Mole – Impact! IV
The cost of a single paper may surprise you. So how much more money will we pay to ensure that each paper (our output) is actually published? 10% of this total cost per paper? 20%? More?
Read Mole’s thoughts on the issue of impact in scientific literature.
preLights – preLights reaches 500 posts!
The success of preLights is down to the hard work of our preLighters. Head over to the preLights website to find out more about our most active early-career-researchers.
Journal Meeting – Cell Dynamics: Host-Pathogen Interface
Registration is now open for the third instalment of the highly successful Cellular Dynamics Meeting Series, which will take place on 17-20 May 2020 and will focus on ‘Host-Pathogen Interface’.
Articles of interest in our sister journals
Allison P. Kann, Robert S. Krauss (Development 2019 146: dev179259)
Anja Katzemich, Jenny Yanyan Long, Vincent Panneton, Lucas A. B. Fisher, David Hipfner, Frieder Schöck (Development 2019 146: dev176339)